CORE--RESEARCH PHARMACY SERVICE

$0P30FY2001CANIH

University Of Arizona, Tucson AZ

Investigators

Linked publications, trials & patents

Paper 39631050 Paper 39622842 Paper 39612086 Paper 39361227 Paper 39312766 Paper 39151774 Paper 39100646 Paper 39075233 Paper 38875929 Paper 38858600 Paper 38826434 Paper 38804255 Paper 38769192 Paper 38759377 Paper 38729260 Paper 38719743 Paper 38715255 Paper 38687603 Paper 38658768 Paper 38639990 Paper 38613866 Paper 38612480 Paper 38474232 Paper 38464045 Paper 38453918 Paper 38386696 Paper 38386396 Paper 38328594 Paper 38313301 Paper 38309054 Paper 38291312 Paper 38215755 Paper 38203706 Paper 38199366 Paper 38164625 Paper 38164604 Paper 38097734 Paper 38097593 Paper 38096366 Trial NCT07214506 Trial NCT06009926 Trial NCT05699603 Trial NCT05237960 Trial NCT05121051 Trial NCT04530552 Trial NCT03708055 Trial NCT03602066 Trial NCT03601507 Trial NCT03578432 Trial NCT03422536 Trial NCT03402230 Trial NCT03376971 Trial NCT03365895 Trial NCT03196180 Trial NCT02581137 Trial NCT02568566 Trial NCT02348203 Trial NCT02326805 Trial NCT02123849 Trial NCT01686165 Trial NCT01433913 Trial NCT01394211 Trial NCT01385280 Trial NCT01370889 Trial NCT01288261 Trial NCT01172028 Trial NCT01097304 Trial NCT01077453 Trial NCT00980395 Trial NCT00978718 Trial NCT00900432 Trial NCT00900341 Trial NCT00898703 Trial NCT00896935 Trial NCT00892268 Trial NCT00841204 Trial NCT00752739 Trial NCT00732498 Trial NCT00721877 Trial NCT00702299 Trial NCT00701857 Trial NCT00699907 Trial NCT00619060 Trial NCT00608634 Trial NCT00601640 Trial NCT00410618 Trial NCT00373022 Trial NCT00363805 Trial NCT00303823 Trial NCT00245024 Trial NCT00091325 Trial NCT00078897 Trial NCT00003307 Trial NCT00003082 Patent 9486545 Patent 9435812 Patent 9415110 Patent 9262824 Patent 5650489 Patent 5510240

Abstract

The Research Pharmacy Shared Service (RPSS) is one of the founding core services for this Cancer Center Support grant. It is responsible for investigation cancer drug inventory and preparation for the Multi- disciplinary Clinics of the Arizona Cancer Center. Located in the clinic area of the first floor, the service prepares over 2,800 investigation agents yearly, facilitated through the funding of a pharmacy technician, Estelle Wesau. Robert Dorr, Ph.D., R.Ph. is funded at 10% and serves as director of the services. He oversees the technician and investigational drug logistics for the entire Center. In addition, Dr. Dorr also prepares samples of investigation topical of injectable formulations of new agents or repackages active and placebo dosages for double-blinded pilot clinical trials. The later service totaled six projects for drug formulation and three projects for double-blind repackaging, respectively. The repackaged investigational agents are primarily used in the Cancer Prevention and Control Research Program. The Research Pharmacy Shared Service provides investigational drug reconstitution for daily clinics in the Cancer Center and as such, swerves a variety of peer-reviewed clinical projects including those of the Southwest Oncology Group (SWOG) and the clinical trials of three large translational research program project grants: the Medical Oncology Program Project, the Colon Cancer Prevention Program Project, and the Chemoprevention of Skin Cancer Program Project. Private (drug company) or other investigational trials may use the service of a when-available charge-back basis with funds used to buy equipment (freezers, computer, infusion pumps, etc.) to enhance the overall service effort. However, federal funding for this service is crucial since there are no charges to patients for preparation of any investigational drug, as it is done to pay for pharmacy services with commercially-available drugs.

View original record on NIH RePORTER →